EUCTR2014-004384-21-Outside-EU/EEA进行中（未招募）不适用
A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures
CB BIOSCIENCES, Inc.0 个研究点目标入组 100 人开始时间: 2015年3月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Eligible subjects who participated in SP925 [2014-004378-40] for treatment of partial-onset seizures
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 10
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •- Receiving any study drug or experimental device other than lacosamide
- •- Meets withdrawal criteria for parent study SP925 [2014-004378-40]
- •- Experiencing ongoing serious adverse event
研究者
相似试验
进行中（未招募）
1 期
A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset SeizuresEUCTR2007-005440-25-FRSCHWARZ BIOSCIENCES, Inc.322
进行中（未招募）
1 期
A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset Seizures Ensayo de extension abierto multicentrico para evaluar el uso a largo plazo de la monoterapia con lacosamida y la seguridad de la momoterapia y el tratamiento complementario con lacosamida en pacientes con crisis parcialesPartial-onset seizures (with and without secondary generalization) Crisis parciales ( con o sin generalización secundaria)EUCTR2007-005440-25-ESSCHWARZ BIOSCIENCES, Inc.322
进行中（未招募）
不适用
A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset SeizuresEUCTR2007-005440-25-ATSCHWARZ BIOSCIENCES, Inc.225
进行中（未招募）
不适用
A continuation study to assess long term safety of Lacosamide (approved drug in Europe) monotherapy and safety of Lacosamide monotherapy and Adjuctive therapy in people with partial-onset seizuresPartial-onset seizures (with and without secondary generalization)MedDRA version: 14.1Level: PTClassification code 10010145Term: Complex partial seizuresSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10040703Term: Simple partial seizuresSystem Organ Class: 10029205 - Nervous system disordersEUCTR2007-005440-25-Outside-EU/EEACB BIOSCIENCES, Inc.294
进行中（未招募）
1 期
A continuation study to assess long term safety of Lacosamide (approved drug in Europe) monotherapy and safety of Lacosamide monotherapyand Adjuctive therapy in people with partial-onset seizuresPartial-onset seizures (with and without secondary generalization)MedDRA version: 17.0Level: PTClassification code 10010145Term: Complex partial seizuresSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 17.0Level: PTClassification code 10040703Term: Simple partial seizuresSystem Organ Class: 10029205 - Nervous system disordersEUCTR2007-005440-25-DKCB BIOSCIENCES, Inc.294